Joan C Domingo Selected Research

stavudine triphosphate

4/2011	Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophy.
4/2010	Relationship between HIV/Highly active antiretroviral therapy (HAART)-associated lipodystrophy syndrome and stavudine-triphosphate intracellular levels in patients with stavudine-based antiretroviral regimens.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Joan C Domingo Research Topics

Disease

9	Lipodystrophy 01/2022 - 01/2006
5	Infections 08/2011 - 01/2006
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 04/2010
3	Insulin Resistance 01/2022 - 11/2010
3	Inflammation (Inflammations) 10/2013 - 03/2008
3	Lipomatosis 11/2006 - 04/2004
2	Dyslipidemias (Dyslipidemia) 01/2022 - 11/2010
2	Obesity 10/2018 - 01/2018
2	HIV Infections (HIV Infection) 01/2018 - 01/2016
2	Neoplasms (Cancer) 11/2017 - 04/2014
2	Necrosis 01/2007 - 01/2006
1	Parkinsonian Disorders (Parkinsonism) 01/2018
1	Type 2 Diabetes Mellitus (MODY) 01/2018
1	Prostatic Neoplasms (Prostate Cancer) 11/2017
1	Encephalomyelitis (Myeloencephalitis) 06/2017
1	Body Weight (Weight, Body) 01/2017
1	Hypertrophy 01/2013
1	Lipoma (Lipomata) 11/2006

Drug/Important Bio-Agent (IBA)

4	fibroblast growth factor 21IBA 10/2018 - 11/2010
2	C-Reactive ProteinIBA 01/2022 - 01/2015
2	Docosahexaenoic AcidsIBA 01/2018 - 06/2017
2	Triglycerides (Triacylglycerol)IBA 01/2018 - 06/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2017 - 11/2010
2	LDL CholesterolIBA 01/2015 - 11/2010
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2013 - 01/2007
2	NucleosidesIBA 08/2011 - 04/2010
2	stavudine triphosphateIBA 04/2011 - 04/2010
2	CytokinesIBA 10/2010 - 01/2007
2	AdipokinesIBA 10/2010 - 01/2006
2	Messenger RNA (mRNA)IBA 01/2007 - 11/2006
1	Hormones (Hormone)IBA 10/2018
1	AndrogensIBA 11/2017
1	Immunoglobulin Fc FragmentsIBA 11/2017
1	Immunoglobulin G (IgG)IBA 11/2017
1	Cancer VaccinesIBA 11/2017
1	LipidsIBA 01/2017
1	Integrase InhibitorsIBA 01/2016
1	elvitegravirIBA 01/2016
1	Monounsaturated Fatty AcidsIBA 01/2015
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2015
1	AntigensIBA 04/2014
1	VaccinesIBA 04/2014
1	Interleukin-18 (Interleukin 18)IBA 10/2013
1	Interleukin-6 (Interleukin 6)IBA 10/2013
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 10/2013
1	Interleukin-8 (Interleukin 8)IBA 10/2013
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2013
1	efavirenz (Sustiva)FDA Link 08/2011
1	Reverse Transcriptase InhibitorsIBA 08/2011
1	Nevirapine (Viramune)FDA Link 08/2011
1	Thymidylate SynthaseIBA 04/2011
1	Biomarkers (Surrogate Marker)IBA 11/2010
1	InterleukinsIBA 10/2010
1	Stavudine (Zerit)FDA LinkGeneric 04/2010
1	ThymidineIBA 04/2010
1	PPAR gammaIBA 11/2006
1	Lys Transfer RNAIBA 11/2006
1	Mitochondrial DNA (mtDNA)IBA 11/2006
1	CCAAT-Enhancer-Binding Protein-alphaIBA 11/2006
1	LeptinIBA 01/2006
1	AdiponectinIBA 01/2006
1	Uncoupling Protein 1IBA 04/2004

Therapy/Procedure

8	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 04/2004
1	Transplantation 01/2013
1	Autologous Transplantation 01/2013
1	Therapeutics 10/2010
1	Aftercare (After-Treatment) 01/2007